検索結果 - Anton Pozniak

結果の絞り込み
  1. 1
    HIV Drug Resistance — An Emerging Threat to Epidemic Control

    HIV Drug Resistance — An Emerging Threat to Epidemic Control 著者: Chris Beyrer, Anton Pozniak

    出版事項 2017
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points

    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points 著者: Alice Raymond, Andrew Hill, Anton Pozniak

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs

    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs 著者: Mariana S. Sousa, Anton Pozniak, Marta Boffito

    出版事項 2008
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  4. 4
    Are new antiretroviral treatments increasing the risks of clinical obesity?

    Are new antiretroviral treatments increasing the risks of clinical obesity? 著者: Andrew Hill, Laura Waters, Anton Pozniak

    出版事項 2019
    全文の入手
    Editorial
    お気に入りに追加
    保存先:
  5. 5
    Has the time come to abandon efavirenz for first-line antiretroviral therapy?

    Has the time come to abandon efavirenz for first-line antiretroviral therapy? 著者: François Raffi, Anton Pozniak, M A Wainberg

    出版事項 2014
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  6. 6
    The treatment of tuberculosis in HIV-infected persons

    The treatment of tuberculosis in HIV-infected persons 著者: Anton Pozniak, Robert F. Miller, Peter L. Ormerod

    出版事項 1999
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  7. 7
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? 著者: Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    出版事項 2018
    Editorial
    お気に入りに追加
    保存先:
  8. 8
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? 著者: Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    出版事項 2018
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study

    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study 著者: Sasikala Rajamanoharan, Nicola Low, Simon B. Jones, Anton Pozniak

    出版事項 1999
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Rapidly declining HIV infection in MSM in central London

    Rapidly declining HIV infection in MSM in central London 著者: Nneka Nwokolo, Andrew Hill, Alan McOwan, Anton Pozniak

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Gonorrhoea in inner London: results of a cross sectional study

    Gonorrhoea in inner London: results of a cross sectional study 著者: Nicola Low, Gavin Daker‐White, David H. Barlow, Anton Pozniak

    出版事項 1997
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics

    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics 著者: Fraser Lewis, G. Hughes, Andrew Rambaut, Anton Pozniak, Andrew Brown

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP

    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP 著者: Victoria Pilkington, Andrew Hill, Sophie Hughes, Nneka Nwokolo, Anton Pozniak

    出版事項 2018
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  14. 14
    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology

    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology 著者: Julia del Amo, Adam S. Malin, Anton Pozniak, Kevin M. De Cock

    出版事項 1999
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  15. 15
    Clinical management of tuberculosis and HIV-1 co-infection

    Clinical management of tuberculosis and HIV-1 co-infection 著者: Charlotte Schutz, Graeme Meintjes, Fahad Almajid, Robert J. Wilkinson, Anton Pozniak

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance

    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance 著者: John Walsh, Anton Pozniak, Mark Nelson, Sundhiya Mandalia, Brian George Gazzard

    出版事項 2002
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis

    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis 著者: Christos Michailidis, Anton Pozniak, Sundhiya Mandalia, Sheena Basnayake, Mark Nelson, Brian Gazzard

    出版事項 2005
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades

    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades 著者: Jacob Levi, Alice Raymond, Anton Pozniak, Pietro Vernazza, Philipp Köhler, Andrew Hill

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy

    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy 著者: Nathan Ford, Zara Shubber, Anton Pozniak, Marco Vitória, Meg Doherty, Catherine Kirby, Alexandra Calmy

    出版事項 2015
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  20. 20
    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load

    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load 著者: Heather Donaghy, Anton Pozniak, Brian Gazzard, Nad A. Qazi, Jill Gilmour, Frances Gotch, Steven Patterson

    出版事項 2001
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: